Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3). | Immunotargets Ther | 2026 | 41710281 | PubTator, text mining | PubMed |
| 3D reconstruction of human liver tissue at cellular resolution. | Sci Adv | 2026 | 41706846 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Antibody-Dependent Enhancement of Viral Infection. | Biochemistry (Mosc) | 2026 | 41702726 | PubTator, text mining | PubMed |
| Regulatory dynamics of IFI44L in systemic lupus erythematosus: the interplay of type I interferon and c-Jun. | Lupus Sci Med | 2026 | 41592906 | PubTator, text mining | PubMed |
| Triptolide in renal disorders: dual roles of therapeutic potential and nephrotoxicity: a narrative review. | Pharm Biol | 2026 | 41562626 | PubTator, text mining | PubMed |
| Aging reshapes the osteosarcoma ecosystem through immune dysfunction and tumor cell reprogramming. | Cell Oncol (Dordr) | 2026 | 41553639 | PubTator, text mining | PubMed |
| Functional classification of antineutrophil cytoplasmic antibody (ANCA) and its relation with clinical parameters of ANCA-associated vasculitis. | Biochem Biophys Rep | 2026 | 41550499 | PubTator, text mining | PubMed |
| Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection. | bioRxiv | 2026 | 41542475 | PubTator, text mining | PubMed |
| Spatiotemporal profiling of endocytic regulators in the immunosuppressive TAM microenvironment of glioma. | Brain Res | 2026 | 41352636 | PubTator, text mining | PubMed |
| Facts and Hopes in Harnessing Macrophage-Mediated Antibody-Dependent Cellular Phagocytosis for Cancer Immunotherapy. | Clin Cancer Res | 2026 | 41329478 | PubTator, text mining | PubMed |
| Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development. | Med | 2026 | 41260224 | PubTator, text mining | PubMed |
| IgG4-related disease in the Japanese population: a whole-genome sequencing study. | Lancet Rheumatol | 2026 | 41197642 | PubTator, text mining | PubMed |
| Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia. | Blood Adv | 2026 | 41061187 | PubTator, text mining | PubMed |
| CD19 and FcγRIIb co-engagement inhibits processes essential to T cell-dependent B-cell responses. | J Immunol | 2026 | 40977622 | PubTator, text mining | PubMed |
| More Than Just Antinuclear Antibodies: IgG Sialylation May Tip the Balance in Autoimmunity. | Arthritis Rheumatol | 2026 | 40931873 | PubTator, text mining | PubMed |
| Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells. | J Hepatol | 2026 | 40882923 | PubTator, text mining | PubMed |
| Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality. | Hepatology | 2026 | 40591396 | PubTator, text mining | PubMed |
| Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations. | Expert Rev Precis Med Drug Dev | 2025 | 42281945 | PubTator, text mining | PubMed |
| Identification of CD320, SLC44A1 and TNFRSF13B as potential novel therapeutic targets for CAR T-cell therapy in multiple myeloma. | Front Med (Lausanne) | 2025 | 41608427 | PubTator, text mining | PubMed |
| Activation of FCGR2A enhances the antitumor efficacy of hPSC-derived CAR-M. | Front Cell Dev Biol | 2025 | 41602835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=4